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issue
Sona Sarmirovaa, Maria Borsanyiovaa, Brigita Benkoovaa, Michaela Pospisilovaa, Rajkumar Arumugamb,
Katarina Berakovac, Pavol Gomolcakd, Jay Reddyb, and Shubhada Bopegamage a
a

Enterovirus Laboratory, Institute of Microbiology, Faculty of Medicine, Slovak Medical University, Bratislava, Slovak Republic; bSchool of
Veterinary Medicine and Biomedical Sciences, University of Nebraska-Lincoln, Lincoln, NE, USA; cMartinske biopticke centrum s.r.o, Zilina,
Slovak Republic; d Immunohistochemical Laboratory, Medical Laboratory Pathology and Cytology, Cytopathos, s.r.o, Bratislava, Slovak
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ABSTRACT

ARTICLE HISTORY

Enteroviral infections are frequent, often asymptomatic in humans and during gravidity.
The present study is an extension of our previous investigations where we had shown
pancreatitis in challenged pups of CVB4-E2-infected dams. Present investigation describes the
effect of gestational infection with this virus on the pancreas of both dams and their challenged
pups. Gravid CD1 outbred mice were orally infected with CVB4-E2 virus at different gestation
times. Pups were challenged orally with the same virus after 25 days of birth. Organs were
collected at selected intervals postinfection (p.i.), and replicating virus and viral-RNA copies
were analyzed. Additional readouts included histopathology and immunohistochemical (IHC)
analysis for localization and identification of Ly6G+ cells (neutrophils), CD11b+ cells (macrophages), and viral protein in pancreatic tissue sections of the infected dams and their challenged
pups. Our results show the presence of replicating virus in the pancreas of infected dams and
their challenged pups, with inflammation leading to chronic necrotizing pancreatitis and atrophy
of pancreatic acini of the dams and their offspring. IHC analysis of the infiltrating cells showed
pronounced Ly6G+ neutrophils in dams only, whereas CD11b+ macrophages were present in
tissues of both, the pups and the dams. Time of infection during gravidity as well as the p.i.
intervals when mice were sacrificed influenced the pancreatic pathophysiology in both groups.
We conclude that coxsackievirus infection during pregnancy is a risk factor for chronic affliction of
the exocrine tissue and could affect endocrine pancreas in the mother and child.
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Introduction
A wide range of clinical manifestations are associated
with enterovirus (EV) infections. In general, these viral
infections are mostly subclinical and may go unnoticed.
Genus Enterovirus of the family Picornaviridae contains
a large number of human viral pathogens, distributed
in seven species Enterovirus A to D and Rhinovirus A to
C (https://talk.ictvonline.org/ictv-reports/ictv_online_
report/positive-sense-rna-viruses/picornavirales/w/
picornaviridae) [1].
Transmission of EVs from a mother to the fetus
and newborn may be antenatal, perinatal, at the time
of delivery, or postnatal [2,3]. Existence of several
case reports suggest that EV infections during pregnancy may cause meningitis, preterm delivery, neonatal myocarditis, fetal growth retardation, or even
embryopathy [4–21]. However, intrauterine transmission of EVs is nevertheless discussed with ambiguity.
Seroepidemiological studies associate coxsackievirus
CONTACT Shubhada Bopegamage
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B4 infection during pregnancy with childhood onset
of type 1 diabetes (T1D) [22–25]. Although EV infections are common, they are not included in the
routine clinical screening tests during pregnancy.
Experimental studies related to the influence of
enteroviral infections on the course of gravidity are
limited [26–34].
Our previous work [26] showed severe inflammation of the pancreatic acinar tissue in homologously
challenged progeny of dams infected during gestation
at different time intervals. However, the study was
limited to only a single time point observation,
namely day 5 postinfection (p.i.) after challenging
the litter of these infected dams. The organs of the
dams were not investigated. The objective of our
present study therefore was to systematically follow
up firstly the maternal infection during pregnancy
(day 3 to day 14 p.i.) and a subsequent homologous
infection of the offspring (day 5 to day 21 p.i.) over
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a longer period than our previous study [26], with
a focus on the pancreas.

RNA copies in the pancreas of dams infected at
different weeks of pregnancy and their
challenged pups

Results

Gravid dams

Observations at later intervals could not be made in the
dams which were infected late during gravidity as mice
delivered on time and nursed the suckling and therefore could not be sacrificed.

Considering our published observations of infiltration
of the acinar tissue in the litter of previously infected
dams [26], we have focused our investigations on the
pancreas. On day 3 p.i. (E.7, E.13, E.20 as in Figure 1),
viral RNA copies in the pancreas of dams infected in
the first week were highest as compared to the pancreas
of mice infected in the second week of gravidity (p <
0.05; p = 0.0007) and third week (p < 0.05; p = 0.0007)
as shown in the graph (Figure 2). The results also
demonstrate that in the pancreas of dams infected in
the second week, viral RNA load was higher than in the
pancreas of dams infected in the third week of gravidity
(p < 0.05; p = 0.04) at day 3 p.i. (E.13 and E.20).
The viral RNA copies were significantly lower
on day 5 p.i. (E.9) than on day 3 p.i (E.7) in the
pancreas of gravid mice infected in the first week of
infection (p < 0.05; p = 0.0008). On the other hand in
the mice infected in the second week of gravidity, the
copies were increased on day 5 p.i. (E.15) as compared
to day 3 p.i. (E.13) (Figure 2).

Replicating virus in selected organs of
experimentally infected dams
Spread of replicating virus was confirmed in most of
the collected organs after three blind passages (P1, P2,
P3). 75% (3/4) placentas of dams infected in the first
week (day 4/E.4) showed replicating virus by the third
blind passage P3 when studied at days 3, 5 and 14 p.i.
All placentas were positive by P3 in dams infected in
the second week (day 10/E.10) at day 5 p.i., and at day 3
p.i., only 50% of placentas were positive in this group
and in the dams infected at day 17/E.17.
Presence of replicating virus was observed in the
umbilical cords in 50% (2/4) of dams (infected
in second week) when checked at day 3 p.i. All umbilical cords showed replicating virus (dams infected in
the first week and third week) (Table 1) and at day 5 p.
i. of the dams infected in the second week.
All heart and pancreatic tissues of infected dams
showed a replicating virus after 3 blind passages.
Mice infected in the third week of gravidity were
not studied longer than day 3 p.i. as they delivered
in a term (day 21).

Challenged pups of infected dams
Highest viral RNA copies were in the pancreas of the
pups (+/+) of previously infected dams as compared to
the group of pups (−/+) of uninfected dams on day 5 p.
i. (Figure 3(a)). However, at this time point,
a statistically significant difference was observed

Table 1. Presence of replicating virus in different organs of the gravid mice.
Number of positives/total number of mice
at different blind passage (P*) levels on selected days after CVB4-E2 infection
Organs of gravid mice infected at different time points

Day 3 p.i.**/E.7***

Week 1 Day 4/E.4

P1

Heart
Pancreas
Umbilical cord
Placenta
Week 2 Day 10/E.10
Heart
Pancreas
Umbilical cord
Placenta
Week 3 Day 17/E.17

4/4
4/4
3/4
3/4

Heart
Pancreas
Umbilical cord
Placenta
P* = passage level.
p.i.** =postinfection.
E.7*** =embryonic age.
– = delivered in term.

P2

Day 5 p.i./E.9
P3

P1

4/4
4/4
4/4
3/4
Day 3 p.i./E.13
3/4
4/4
3/4
4/4
2/4
2/4
2/4
2/4
Day 3 p.i./E.20

4/4
4/4
4/4
3/4

3/4
4/4
3/4
2/4

2/4
2/4
3/4
2/4

4/4
4/4
4/4
2/4

4/4
4/4
4/4
2/4

4/4
4/4
2/4
2/4

P2

4/4
4/4
4/4
2/4
Day 5 p.i./E.15
4/4
4/4
4/4
4/4
4/4
4/4
4/4
4/4
–
–
–
–

–
–
–
–

Day 14 p.i./E.18
P3

P1

P2

P3

4/4
4/4
4/4
3/4

2/4
3/4
2/4
0/4

4/4
4/4
4/4
1/4

4/4
4/4
4/4
3/4

4/4
4/4
4/4
4/4

–
–
–
–

–
–
–
–

–
–
–
–

–
–
–
–

–
–
–
–

–
–
–
–

–
–
–
–
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Total gravidity period (three trimesters of 1 week each)

1

2

week 1
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week 3

Infection

Infection

Infection
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4

5

6

7

8

9

10

Collection of
organs at days
3, 5 and 14 post
infection

11

12

14

13

15

16

17

18

19

20

21

Embryonic (E)
age in days

Day 3 p.i.*

Day 5 p.i.

Day 5 p.i. **

Day 3 p.i.

Day 14 p.i.

Day 3 p.i.

Figure 1. Schematic diagram: Gestational (G) period, embryonic (E) age, infection timings, and organ collection schedules.

Infected on day 4 gravidity
1.00E+09

Infected on day 10 gravidity

1.00E+08

Infected on day 17 gravidity

RNA copies/ml

1.00E+07
1.00E+06
1.00E+05
1.00E+04
1.00E+03
1.00E+02
1.00E+01

0

3

5

14

Days post infection

Figure 2. Viral RNA load in pancreas of dams infected during gravidity.

between the +/+ and – /+ pups of dams infected on day
10 (E.10) of gravidity (p < 0.05, p = 0.0103).
On day 12 p.i. as seen in Figure 3(b), only a few mice
(mainly the +/+ pups) showed the presence of viral
RNA, with lower copies in the heart as compared to
the pancreas (heart data not shown). On day 21 p.i.

similarly, lower copies of RNA were observed only in
the pancreas of few pups, belonging to groups +/+
and –/+ (Figure 3(b,c)).
Pups +/– did not show the presence of either replicating virus or viral RNA by quantitative real-time RTPCR and was therefore not carried out in these pups.
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1.00E+09
Day 17 +/+

1.00E+08
Day 10 +/+

1.00E+09

1.00E+07
Day 17 -/+

Pup4 Day 4 +/+
Pup2 Day 10 +/+
Pup5 Day 10 -/+

P2 D10 +/+

1.00E+07

Pup3 Day 17 +/+

Day 4 -/+

1.00E+05

Day 10 -/+

1.00E+04
1.00E+03

Pup4 Day 17 +/+

1.00E+06

RNA copies/ml

RNA copies/ml

1.00E+06

Pup2 Day 4 +/+

P4 D4 +/+ *
P2 D4 +/+

1.00E+08

Day 4 +/+*

Pup5 Day 17 +/+
1.00E+05
P5 D10 -/+

P5 D17 +/+

1.00E+04
1.00E+03

1.00E+02

1.00E+02

1.00E+01

1.00E+01

P3 D17 +/+
P4 D17 +/+

Day 12 post infection

Day 5 post infection

a

b

1.00E+09
Pup3 Day 4 -/+

RNA copies/ml

1.00E+08

Pup4 Day 4 -/+
Pup4 Day 10 +/+

1.00E+07
1.00E+06

Pup1 Day 17 +/+

P3 D4 -/+*

Pup3 Day 17 +/+
1.00E+05
1.00E+04
P3 D17 +/+

1.00E+03
P4 D10 +/+

1.00E+02

P4 D4 -/+
P1 D17 +/+

1.00E+01

Day 21 post infection

c

Figure 3. (a) Viral RNA load in pancreas of the challenged pups of CVB4-E2-infected and control dams. (b) Viral RNA load in pancreas
of “individual” challenged pup showing positivity at day 12 postinfection of CVB4-E2-infected and control dams. (c) Viral RNA load in
pancreas of “individual” challenged pups showing positivity at day 21 postinfection of CVB4-E2-infected and control dams.
*+/+ both mother and pup infected; −/+ mother mock-infected and pup-infected, P = pup; 1, 2, 3, 4, 5 number code of individual pup for
that catergory. Days 4, 10, and 17 show the time of infection of the dam.

Histopathological observations in the
pancreatic tissues of dams
The pancreas of the mock-infected dams were without
any histopathological changes in the acinar, endocrine,
and peripancreatic tissues (Figure 4(a,b)). Table 2 shows
the infiltration grades in the pancreas of the infected mice
at different time points. Dams infected on day 4/E.4 of
gestation show focal interstitial infiltrates with lymphocytes in the peripancreatic fat tissue and in the acinar
tissue on day 3 p.i./E.7 (Figure 4(c,d)). We did not observe
any infiltration in the islets (endocrine pancreatic tissue)
at this time point. The acinar infiltration increased intensively on day 5 p.i./E.9. On day 14 p.i./E.18, the exocrine
(acinar) pancreas had recovered and the tissues were
normal without changes.
In the pancreas of dams infected on day 10/E.10, we
observed little infiltration of the peripancreatic fat and
the acinar tissues on day 3 p.i./E.13. The acinar tissue
infiltration increased intensively on day 5 p.i./E.15
denoting a stage of transition from the acute inflammatory phase to a subacute condition with reparative
changes, where lymphoplasmacytic inflammation was

already prevalent, and numerous incipient capillaries
were present, with the formation of inflammatory granulation in the defunct parenchymal pancreatic tissue.
The lymphocytic infiltrates were seen in the pancreatic
islets (Figure 4(e)). Infiltrates were not observed in the
pancreatic tissue of dams infected on day 17/E.17 of
gestation on day 3 p.i./E.20.

Histopathological observations in pancreas
tissues of challenged pups of the infected dams
Our focus is on the pancreas of challenged pups considering the fact that histopathological changes (infiltration) in
heart were mild only on day 5p.i. in the +/+ pups and were
absent in −/− pups as observed in our previous studies [26].
Tables 3–5 show histopathological changes of the pancreatic tissue with the number of affected challenged pups.
Each table represents a group of challenged pups with
a maternal infection at a particular time during
gestation: day 4/E.4, day 10/E.10, and day 17/E.17.
Designation used for the groups of pups of the infected
or mock-infect dams were: pups challenged with the virus

VIRULENCE
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(b)

(c)

(d)

(e)

Figure 4. Histopathological changes in pancreas tissues of CVB4-E2 infected and control dams. (a) Absence of changes in the
acinar and endocrine pancreas tissue (20×) and in the peripancreatic fat tissue (20×) (b) of a dam mock infected on day 4/E.4
sacrificed on day 3 p.i./E.7. (c) Focal infiltration in the peripancreatic fat tissue of virus-infected dam on day 10/E.10, sacrificed on day
3/E.13 p.i. (20×). (d) Pancreatitis in the acinar tissue showing inflammatory phase in the tissue of dam infected with the virus on day
4/E.4 sacrificed on day 3 p.i./E.7 (20×). (e) A stage of transition from acute to a subacute condition with reparative changes,
lymphoplasmacytic inflammation with several incipient capillaries, and formation of inflammatory granulation in the defunct
parenchymal pancreatic tissue. The lymphocytic infiltrates were also observed in the pancreatic islets of dams infected with the
virus on day 10/E.10 (20×) and sacrificed on day 5 p.i./E.15.

were +/+ and −/+; pubs challenge with PBS (mockinfected) +/− and −/− . In Tables 3–5 records the grades
of histopathological changes. Figure 5(a–f) show the actual
histopathological changes.
Pancreas tissues of the mock-infected control pups
(−/−) were normal in all groups throughout the experiments. In pups (−/+) of dams mock-infected on day 4/
E.4, the pancreas showed peripancreatic fat infiltration
ranging from grade +1 (Figure 5(c)) to +3 (Figure 5(d))
at day 5 p.i. The infiltration subsided in this group of pups.
On the other hand, pups of the other two virus-infected
groups +/+ and +/– showed mild peripancreatic infiltration
from day 12 p.i. to day 21 p.i. (grade +1 to +2) as shown in
Table 3.
In the pancreas of pups +/+ of dams infected on day
10/E.10, the acinar tissues showed acute pancreatitis
at day 5 p.i. (after these pups were challenged).
Moreover, by day 21 p.i. in this group of pups, chronic

pancreatitis was observed with infiltration of the islets. In
the pups of dams infected on day 17/E.17, pancreatitis
with pancreatic atrophy (grade +1 to +4 infiltration) was
detected at day 12 p.i. (Figure 5(g,f)).

Immunohistochemical (IHC) analysis
Localization of the virus by IHC analysis of viral protein (VP1) showed the presence of virus in the acinar
tissue as well as the islets in the dams infected at day
17/E.17 of gestation as early as day 3 p.i./E.20. VP1 was
observed in the exocrine pancreas and peripancreatic
fat tissue in the pancreatic tissues of the pups of CVB4E2-infected dams. However, some of the islets of the
pups did not show VP1 (Figure 6(a–e)) while others
showed mild to almost absence of positivity.
Immunohistological staining was done for analyzing
infiltration of CD11b+ and Ly6G+ cells in the pancreas of
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Table 2. Grades of destruction in the pancreas tissues of CVB4-E2 infected dams.
Infiltration status in the pancreas
at different days post-CVB4-E2 infection
Pancreatic tissue of gravid mice infected
at different time points

Number of
positives/
total

Week 1 Day 4/E.4

Number of
positives/total

Grade

D3 p.i.*/E.7**

Number of
positives/
total

Grade

Day 5 p.i./E.9

Peripancreatic fat
Acinar
Endocrine
Week 2 Day/E.10
Peripancreatic fat
Acinar
Endocrine
Week 3 Day/E.17

2/4
+1
2/4
+1 to +2
0/4
None
Day 3 p.i./E.13
2/4
+1
2/4
+1
3/4
+1
Day 3 p.i./E.20

4/4
+1
2/4
+3 to +4
0/4
None
Day 5 p.i./E.15
3/4
+1
4/4
+1 to +4
4/4
+2 to +4

0/4
0/4
0/4

Peripancreatic fat
Acinar
Endocrine

0/4
0/4
0/4

NA

NA

N
N
N

Grade

Day 14 p.i./E.18
N
N
N

NA

p.i.** =postinfection.
E.7*** =embryonic age.
N = no infiltration.
NA = not applicable – mice delivered in term.

Table 3. Histopathology of pancreas tissues of challenged pups of dams infected in the first
week of gestation (day 4/E.4).
Infiltration status in the pancreas
at different days post-CVB4-E2 or mock infection

Pancreatic tissue of pups

Number of
positives/
total

Grade

Number of
positives/
total

Day 5 p.i. *

Grade

Day 12 p.i.

Number of
positives/
total

Grade

Day 21 p.i.

Peripancreatic fat
Acinar
Endocrine

0/5
2/5
0/4

None
+1 to +2
0

+/+**
1/5
2/5
0/5
−/+

+2
+4
None

3/5
0/5
0/5

+1
None
None

Peripancreatic fat
Acinar
Endocrine

4/5
0/5
0/5

+1 to +3
None
None

0/5
0/5
0/5

None
None
None

0/5
0/5
0/5

None
None
None

Peripancreatic fat
Acinar
Endocrine

0/5
0/5
0/5

None
None
None

2/5
0/5
0/5

+1
None
None

3/5
0/5
0/5

+1
None
None

Peripancreatic fat
Acinar
Endocrine

0/5
0/5
0/5

None
None
None

0/5
0/5
0/5

None
None
None

0/5
0/5
0/5

None
None
None

+/−

−/−

E.4 = embryonic age.
p.i.* = postinfection.
+/−** dam virus-infected, pup mock-infected.
−/+ dam mock-infected, pup virus-infected.
+/+ dam virus-infected, pup virus-infected.
−/− dam mock-infected, pup mock-infected.
None = no infiltration.

the dams and their pups. CD11b+ (Figure 7(a,b,d)) infiltration was present in both the dams and the pups at
acute and late (day 21 p.i.) phases of infection. Presence
of Ly6G+ (Figure 7(c)) was identified in the pancreas of
the dams. However, Ly6G+ cells were almost absent in
the infiltration at the acute and late phases of infection.

Discussion
The most significant outcome of our study is that the
infection of dams with CVB4-E2 during the second
week of gravidity (day 10/E.10) and the challenge of
their offsprings with the homologous virus leads to the

VIRULENCE

Table 4. Histopathology of pancreas tissues of challenged pups of dams infected in the second
week of gestation (Day 10/E.10).
Infiltration status in the pancreas
at different days post-CVB4-E2 or mock infection
Pancreatic tissue
of pups

Number of
positives/
total

Grade

Day 5 p.i.*

Number of
positives/total

Grade

Number of
positives/
total

Day 12 p.i.
+/+**

Grade

Day 21 p.i.

Peripancreatic fat
Acinar
Endocrine

0/5
3/5
0/5

None
+1 to +2
0

1/5
2/5
0/5

+2
+2 to +4
None

0/5
5/5
4/5

None
+ 3 to +4
+1 to +2

Peripancreatic fat
Acinar
Endocrine

4/5
0/5
0/5

+1
None
None

−/+
1/5
0/5
0/5
+/−

+1
None
None

2/5
0/5
0/5

+1
None
None

Peripancreatic fat
Acinar
Endocrine

5/5
0/5
0/5

+1 to +2
None
None

1/5
0/5
0/5

+1
None
None

3/5
0/5
0/5

+1
None
None

Peripancreatic fat
Acinar
Endocrine

0/5
0/5
0/5

None
None
None

−/−
0/5
0/5
0/5

None
None
None

0/5
0/5
0/5

None
None
None

E.10 = embryonic age.
p.i.* = postinfection.
+/−** dam virus-infected, pup mock-infected.
−/+ dam mock-infected, pup virus-infected.
+/+ dam virus-infected, pup virus-infected.
−/− dam mock-infected, pup mock-infected.
None = no infiltration.

Table 5. Histopathology of pancreas tissues of challenged pups of dams infected in the third week
of gestation (day 17/E.17).
Infiltration status in the pancreas
at different days post-CVB4-E2 or mock infection
Pancreatic tissue
of pups

Number of
positives/
total

Grade

Day 5 p.i.*
Peripancreatic fat
Acinar
Endocrine

3/5
2/5
0/5

+1 to +2
+3 to +4
None

Peripancreatic fat
Acinar
Endocrine

4/5
0/5
0/5

+1 to +2
None
None

Peripancreatic fat
Acinar
Endocrine

3/5
0/5
0/5

0 to +1
None
None

Peripancreatic fat
Acinar
Endocrine

0/5
0/5
0/5

None
None
None

E.17 = embryonic age.
p.i.* = postinfection.
+/−** dam virus-infected, pup mock-infected.
−/+ dam mock-infected, pup virus-infected.
+/+ dam virus-infected, pup virus-infected.
−/− dam mock-infected, pup mock-infected.
None = no infiltration.

Number of
positives/total

Grade

Day 12 p.i.
+/+**
4/5
+1 to +4
3/5
+3 to +4
0/5
None
−/+

Number of
positives/
total

Grade

Day 21 p.i.
3/5
5/5
0/5

+2 to +3
+1 to +4
None

2/5
0/5
0/5
+/−
1/5
0/5
0/5
−/−

+1
None
None

0/5
0/5
0/5

None
None
None

+1
None
None

3/5
0/5
0/5

+1
None
None

0/5
0/5
0/5

None
None
None

0/5
0/5
0/5

None
None
None
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Figure 5. Histopathological changes in the pancreatic tissues of the virus challenged pups of CVB4-E2 infected and pups of mock
control dams.
(a) Absence of changes in the acinar and endocrine pancreatic tissue (20×) dam infected on day 4/E.4 of gestation and virus challenged pup
sacrificed on day 5. (b) Peripancreatic fat tissue (20×) of a mock-infected dam on day 4/E.4 of gestation and (−/−) pup mock challenged and
sacrificed on day 5 p.i. (c) Mild and severe (d) forms of infiltration in the peripancreatic fat tissue of a virus challenged two different pups
(−/+) of a dam mock-infected on day 4/E.4 of gravidity (20×), pups sacrificed on day 5 p.i. (20×). (e) Chronic pancreatitis and atrophy of the
acinar tissue of a challenged pup (+/+) sacrificed on day 5 p.i. born to dam infected with virus on day 10/E.10 of gravidity, (f) chronic
pancreatitis and atrophy of the acinar tissue and infiltration in the endocrine islet of a challenged pup (+/+) sacrificed on day 21 p.i. (20×)
born to dam infected with the virus on day 10/E.10 (20×) in the tissue of pup sacrificed on day 21 p.i., (g) chronic pancreatitis in the acinar
tissue of the virus challenged pups (+/+) of dam infected on day 17/E.17 of gestation day, pup sacrificed on day 12 p.i., absence of
infiltration of the islets (20×), (h) chronic pancreatitis and atrophy in another challenged pup (+/+) sacrificed on day 12 p.i. (20×) of dams
infected on day 17/E.17 of gestation day.

affliction of the endocrine pancreas. In addition, the
types of infiltrating cells between the infected dams and
their challenged pups differed.
We have demonstrated that virus administered
orally during the second week of gestation (day 10/
E.10) caused pancreatitis which was severe on day 3
p.i./E.13 and increased to an acute inflammatory phase

by day 5 p.i./E.15 showing infiltration in the exocrine
tissue as well as in the islets (endocrine). Remarkably,
the pups +/+ of these dams showed chronic pancreatitis
and pancreatic atrophy with infiltration in the islets
by day 21 p.i., although some pups from other groups
such as the progeny (−/+) and pups of dams infected
on day 4/E.4 and day 17/E.17 showed the presence of
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Figure 6. Localization of VP1 in the pancreatic tissue. (a) Absence of VP1 in the islet and exocrine tissue of a mock-infected pup
of a dam mock infected on day 4/E.4 (−/−) (20×), pup sacrificed on day 5 p.i. (b) Presence of VP1 in the islet and exocrine tissue
on day 3 p.i./E.20 of a dam infected with CVB4-E2 on day 17/E.17. (c) Presence of VP1 in the exocrine tissue but absence in the islet
of virus challenged pup of a dam infected on day 10/E.10 (+/+), and of dam at day 17/E17. (d) Pups sacrificed on day 5 p.i. (20×). (e)
Peripancreatic fat tissue showing VP1 positivity at day 5 p.i. in the pancreas of a virus challenged pup of a mock-infected dam (20×).

viral RNA at day 12 and day 21 p.i. and higher virus
load. Presence of VP1 was mild or absent at day 21 p.i.
in these tissues. We have shown that the islets were
affected at later days p.i. in both the mother and the
challenged offspring. We consequently suggest that islet
infiltration or the chronicity was not related to (1)
presence of viral RNA, (2) the number of copies of
viral RNA, and (3) presence of VP1 in the islets but is
influenced by the time of infection of the gestating mice
showing that factors other than the virus can potentially attract the infiltrating cells into the islets in these
mice. The other groups of dams as seen in Table 2 and
offsprings (Tables 3–5) showed pancreatitis in the acinar tissue, but the islet infiltration was absent.
Different groups [26–40] have reported adverse outcomes on the course of gravidity after infection in the
first or second weeks of gestation and even third week
[26]. Some authors [28,29,35] attributed the adverse
effects to the susceptibility of the fetus to the virus
resulting in infection. Other researchers [27] suggest

virus-induced pancreatic exocrine insufficiency in the
mothers (dams) accompanied by a protein deficiency
and hepatic-cell vacuolation. Whereas other groups
[34,37] associate the damaging effect on the gravidity
to the presence of virus in reservoirs such as the placenta and other tissues leading to the infection of the
embryos. Expression of coxsackie-adenovirus receptors
in the placenta, uterus, and dominantly in the embryonic brain and cardiac cells have been described [38,39],
and possible physiological changes in the hormone
levels were suggested by others [32]. In the present
study, replicating virus was present in the umbilical
cords and placentas by three passages. Our results suggest that the passage of virus transmission via placenta
is possible. We contemplate that the amount of virus
transmitted may differ from individual to individual
because all placentas were not positive at day 5 p.i.
This difference can be explained, as a variation due to
the outbred immunocompetent (CD1) mouse strain
used by us and not an inbred strain. Here, we need to

216

S. SARMIROVA ET AL.

a

b

c

d

Figure 7. CD11b+ macrophage and LY6G+ neutrophils localization.
(a) CD11b+ macrophage and (c) LY6G+ neutrophils in abundance seen in the pancreas tissue infected with CVB4-E2 on day 4 (E.4), collected
on day 3 p.i. from a dam; (b) CD11b+ macrophages observed in the pancreas tissue collected on day 5 p.i. of a challenged pup of dam
infected with CVB4-E2 on day 4 (E.4) whereas (d) shows CD11b+ macrophages seen in the pancreas tissue collected on day 21 p.i. of
a challenged pup of dam infected with CVB4-E2 on day 17 (E.17).

mention that this part of our study is limited, and we
have pooled pieces of umbilical cords/dam and placentas/dam at a single time point for the preparation of the
organ suspensions.
Infection of gravid mice by different viruses has been
discussed and reviewed [41]. This review underlines the
necessity to explore disease mechanisms caused by
viruses which have a potential to cause fetal morbidity
and mortality. The authors have focused on human
cytomegalovirus, rubella virus, human immunodeficiency virus, and herpes zoster virus. It appears that
the viruses which have a direct cytopathic effect (CPE)
depending on its life cycle may have a direct effect on
the developing placenta and fetus. On the other hand,
the viruses that induce a shift in the immune profile
from anti-inflammatory to proinflammatory induction
of cytokines may affect the developing fetus and its
immune system. Futhermore in case of rubella and
other viruses such as coxsackieviruses, neonatal T cells
react with viral peptides and cross-react with an antigen
in the insulin-producing pancreatic beta islet cells
resulting in an autoimmune destruction of the islet
cells. We therefore studied the basic differences in the
infiltrating cells of the pancreas. Infiltrating cells,
CD11b+ and Ly6G+, were analyzed. Our immunohistological staining results of the pancreas of the dams
and their pups showed the pronounced presence of
Ly6G+ only in the dams, whereas CD11b+ infiltration
was present in both the dams and the pups at different
intervals. The first direct implication of this finding is

that there is a difference between the immune
responses to the infection in the above two groups.
We may therefore predict a difference in the production of cytokines and downstream inflammatory reactions. Ly6G protein is limited to neutrophils [42].
Monocytes, macrophages, lymphocytes, and plasmacytoid dendritic cells (DCs) do not possess this protein.
Ly6G expression is high in cells recruited to inflamed
sites. Furthermore, CD11b+Ly6C+Ly6G- and CD11b
+Ly6C+Ly6G+ can migrate to the site of virus infection
[42]. These cells are known to initiate different functions that control virus replication, prevent systemic
spread of virus, but also reduce tissue damage.
Presence of CD11b+ was suggested to show an earlyonset infection or suspected infection in infants at risk
or recent infections [43]. Rechallenge of immunized
mice with viruses lymphocytic choriomeningitis virus
and vesicular stomatitis virus, after maternal respiratory syncytial virus infection, has been shown to alter
postnatal offspring immunity [44]. The Ly6C+Ly6G+
cells that infiltrate into the site can mediate both effector (Type I interferon production) and immunomodulatory (reduction of tissue damage) properties in
response to virus infection [42]. Presence of these
cells is important for the protection of tissue from
further damage mediated by the inflammatory
response. Besides the macrophages, neutrophils are
also known to be involved in the inflammatory
responses induced by a number of viral infections
[45,46]. During herpes simplex virus infections,
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neutrophils have been shown to play a clear role in
limiting virus replication [47–49]. Taking into consideration the published literature and our own results, we
may contemplate that the presence of the Ly6G+ cells
in the infected dams plays a role in the virus clearance
and tissue recovery in the dams which is a typical
reaction to virus-infection. Whereas the atypical
absence of these Ly6G+ cells in the pancreas of infected
offsprings is peculiar and maybe an influence of the
infection during pregnancy may predict a slow viral or
antigen clearance and future tissue damage. Although
this may explain the chronicity and severe pancreatitis
in the progeny, we will have to investigate further why
the neutrophils are absent.
Accumulation of interferon (IFN)-gamma secreting
T cells within the central nervous system (CNS) was
suggested to limit Ly6G+ neutrophil infiltration during
the mouse hepatitis virus -JHM strain infection
through inhibition of macrophage inflammatory protein (MIP)-2 expression [50]. The absence of Ly6G+ in
the infiltration of the challenged pups and observation
of chronic atrophy in the acinar tissue point to an
imbalance in the offspring-immune system which may
lead to autoimmunity by tipping the balance between
innate and adaptive immune responses. Alternatively, it
is possible that the occurrence of chronic atrophic
acinar tissue in the absence of inflammation may result
from events independent of immune mechanisms.
Investigations into these aspects may shed new insights
into the development of acinar pathologies in enteroviral infections.
The mechanism of in utero transmission of viruses
depends on the infecting virus. We have to also consider that the development and formation of the pancreas in rodents starts at E.8.0–10.0 immediately after
closure of the anterior endoderm. A thickening of the
endoderm (bud) appears dorsally with another bud is
formed on the ventral side (called as dorsal and ventral
endoderms). The two buds develop in opposite directions and fuse to form the pancreas. Formation of islets
and expression of several antigens takes place, such as
pancreatic and duodenal homeobox (Pdx1), motor neuron and pancreas homeobox 1 (Hlxb9), pancreas associated transcription factor 1a (Ptf1a), homeobox
protein Nkx-6.1 (Nkx6-1), and homeobox protein
Nkx-2.2 (Nkx2-2) in the common pancreatic progenitor cells in the epithelium with homeobox protein Nkx6.2 (Nkx6-2) and SRY (sex-determining region Y)-box
9 protein (Sox9) starts also at this period of the embyonic development [51,52]. We had hypothesized possible
mechanisms which could induce pancreatic pathological changes in the offsprings (+/+) of infected dams
[26]. In this study, we show that (a) histopathological
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changes were independent of the following: the amount
or presence of viral RNA; amount of viral RNA copies
and presence of the VP1 in the tissue; (b) the mechanism of tissue necrosis and infiltration may result from
altered innate immune mechanism of the challenged
pups of the infected dams and this response differs
from the maternal innate immune response and not
the enhanced adaptive immunity. Taken together, our
data may also point to a possibility that the pathological
changes in the pancreas occur primarily due to viral
damage with the first initial exposure to the virus or
that viral antigens are likely to persist in those affected
cells. To this end, it may be worth investigating to
determine the transcriptome profiles in healthy vs. diseased tissue with an expectation that the differentially
expressed genes may in fact determine the pathological
outcomes. We plan to pursue these aspects in the future
studies.
Our model and data are in line with the proposition
suggested by other authors [22–25,53,54] that there is
an association between maternal enteroviral infection
during pregnancy and T1D in their children in the
seroepidemiological studies.
In conclusion, our model shows that CVB4-E2 infection during gravidity influences the histopathology of
the pancreas of both infected dams and their challenged
pups. The infection leads to chronic changes in the
pancreas at late stages (days p.i.). We also suggest that
more attention should be directed toward enteroviral
infections during pregnancy which may have consequences on the health of the offspring.

Material and methods
Virus and cells
Coxsackievirus B4-E2 was kindly provided by Prof.
J. Galama (Department of Microbiology, Radboud
University, Nijmegen, the Netherlands) and
Prof. M. Roivainen (Enterovirus Laboratory,
Department of Virology, National Public Health
Institute, Helsinki, Finland), with permission from
Prof. J. W. Yoon (Department of Microbiology and
Infectious Diseases, Julia McFarlane Diabetes Research
Centre, Faculty of Medicine, University of Calgary,
Alberta, Canada). The virus was propagated in Green
monkey kidney (VERO) cells. Human epidermoid
carcinomas of the larynx (Hep-2) cells (Office of
Public Health, Bratislava, Slovak Republic) were used
for virus isolations from organs. These cells are more
sensitive to primary isolation from the mouse organs.
Cells were grown in Eagle’s Minimum Essential
Medium (EMEM) and supplemented with 5–10% heat-
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inactivated fetal bovine serum for cell growth or 2% for
cell maintenance and infection, 100 U/ml penicillin
(PNC), 100 µg/ml streptomycin (STM), and 1%
HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic
acid ).

Mice
The experimental mouse study and protocols were
reviewed and approved by the Institutional Animal
Ethics Committee of the Slovak Medical University followed by the State Veterinary and Food Control
Authority of the Slovak Republic (dated 22 March 2007,
number C.k Ro 3035/07-221/3). All rules and regulations
were followed according to the requirements of the
Animal Ethics Procedures and Guidelines of the Slovak
Republic.
The mice were maintained in the specific pathogen-free Laboratory Animal Facility of the Slovak
Medical University in Bratislava. All mice had free
access to food and water and were kept in rooms
controlled for temperature (22 ± 0.5°C), automatic
light, reverse 12/12 h light/dark cycle, and humidity
(55% ± 5%).
CD-1 outbred male and female mice (8 weeks old)
weighing about 25 g were obtained from Faculty of
Medicine Masaryk University, Brno, Czech Republic.
Mice were caged with sterile bedding, water, and commercial food pellets (Topdovo, Trnava, Slovak
Republic).

Infection during gestation
After the quarantine period of 10 days, one male mouse
per 3 female mice was placed in a single cage for
planned gestation. The female mice were checked
daily. Increase in weight of the female mice was
noted, and vaginal plugs were checked to estimate the
exact time of gestation.
Infection of dams
Mice were infected at three different time points: days
4/E.4 (first week), 10/E.10 (second week), and 17/E.17
(third week) of gestation. Figure 1 shows the schematic
diagram of the gestational period of mice with the
E age, time points at which the dams were infected
with the virus, and the days p.i. when these mice were
dissected.
The gravid dams were inoculated either with 0.2 ml
of CVB4-E2 at a dose of 1 × 105.5 TCID50 or with
0.2 ml of phosphate-buffered saline (PBS) by oral
route as described by Bopegamage et al. [35].

Infection of pups
Pups were separated from their mothers 3 weeks after
birth (natural time for weaning) and put into separate cages. To reduce the effects of gender difference,
only male pups were used for the present study (the
female pups were kept for another study). The pups
were challenged with 0.2 ml of 105.5 TCID50 of
CVB4-E2 or PBS, 4 days after weaning (25 days
after birth).
Litter groups
Litter of the dams infected on day 4/E.4 (first week)
of gravidity were challenged with CVB4-E2 (+/+);
litter of the dams infected with virus on day 4/E.4
(first week) were challenged with PBS (±); litter of
the dams mock-infected on day 4/E.4 (first week)
were challenged with CVB4-E2 (−/+); litter of the
dams mock-infected on day 4/E.4 (first week) of
gravidity were challenged with PBS (−/−). Similar
combinations of groups were formed with the litter
of the dams infected on day 10/E.10 (second week)
and day 17/E.17 (third week).

Organ collection from infected mice
Infected dams were sacrificed on different days p.i.
(Figure 1). Dams orally infected in the first week of
gravidity were dissected with four mice per time interval,
on days 3, 5, and 14 p.i. Similarly, gravid mice infected in
the second week of gestation were dissected (four per
time interval) on days 3 and 5 p.i., and four dams from
the last group infected in the third week of gravidity were
dissected on day 3 p.i. Control (mock-infected) mice
were parallelly sacrificed. Blood, heart, pancreas (dams
and pups), placenta, and umbilical cords were collected
(from dams). Placenta and umbilical cords were each
pooled/dam due to small sample size.
CVB4-E2 challenged pups and the mock-infected
control pups (five mice from each group) were sacrificed at selected time points, on days 5, 12, and 21 p.i.;
blood, heart, and pancreas were collected as described
previously [53].

Evaluation of infectious virus in organ
suspensions
Organ suspensions from the snap-frozen tissues were
prepared, and blind passages were performed as
described previously [55,56]. The resulting supernatants were collected, and antibiotics (200 U/ml PNC
and 200 μg/ml STM) were added. The organ suspensions were frozen at −80°C and used for blind passages in tissue cultures. We did not titrate the virus
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in the organs but made blind passages. The absence
of CPE in the first passage does not mean the
absence of replicating virus.
Twenty-four-hour monolayers of Hep-2 cell line
grown in single-use tissue culture flasks (50 ml)
were infected with 0.5 ml of the original organ suspensions. After 45-min incubation at 37°C, medium
EMEM was supplemented with 2% fetal bovine
serum and 1% HEPES, and antibiotics (PNC 100 U/
ml, STM 100 μg/ml) was added. Cultures were incubated at 37°C and CPE was checked till day 5 p.i. If
CPE was observed, the flasks were freeze-thawed two
times and suspensions were centrifuged at 1000 g, 4°
C, for 20 min (Minifuge T, Heraeus Sepatech). The
same procedure was followed if CPE (blind passages)
was not observed at day 5 p.i. Supernatants were
used for further infection of cell monolayers. Three
blind passages were carried out with organ suspensions of the infected mice; organs of the control mice
were passaged only once. All passages of the infected
organs were stored at −80°C.
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Real-time reverse transcriptase-PCR (real-time
RT-PCR)
Quantification of the isolated RNA was performed by
using the EliGene® Enterovirus LC Kit (Elisabeth
Pharmacon) according to the manufacturer’s instructions. RNA was reverse-transcribed at 55°C for 15 min
followed by one cycle of denaturation at 95°C for 5
min. PCR amplification was carried out for 50 cycles at
95°C for 15 s, at 55°C for 30 s, and at 72°C for 25 s. The
last step was followed by one cycle at 40°C for 1 min.
Real-time RT-PCR was performed on the CFX96TM
Real-Time system (Bio-Rad).

Histolopathological analysis
The tissues section of the pancreas and heart were examined for evidence of inflammatory, necrotic, and morphological changes. Serial 4–7-µm-thick sections of formalin
fixed paraffin embedded heart and pancreas tissues were
stained with haematoxylin-eosin and graded (1–4) for
infiltration and necrosis as described previously [55,56].

RNA extraction
RNA extraction from snap frozen organs has been
described in our previous study [55] using the
PureLink® RNA Mini Kit according to the manufacturer (Invitrogen, USA).

Reverse-transcription polymerase chain
reaction (RT-PCR) and nested PCR analysis
RT-PCR and nested PCR have been described previously [35,37,38]. PCRs were performed in T100TM
Thermal Cycler (Bio-Rad). Both cDNA synthesis and
cDNA amplification were performed in a single tube
by using the SuperScriptTM III One-Step RT-PCR
System
with
Platinum®Taq
High
Fidelity
(Invitrogen). For the nested reaction, Platinum®
PCR SuperMix (Invitrogen) was used. The primers
directed to the highly conserved sequences in the 5
´untranslated region of the EV genome were
obtained from Microsynth (Germany). Positive and
negative RNA control, beta-actin internal controls,
DNA control, and water blank controls were
included in each run.
The PCR products were separated on a 2% agarose
gel stained with ethidium bromide, at 150 V, 400 mA
for 1.5 h, visualized, and documented by UV illumination in Gel Documentation XR+ Imaging System
(Bio-Rad).

IHC analysis
Viral protein was localized in the pancreas of dams and
the pups by using primary antibody with an epitope for
the VP1 (Monoclonal Mouse Anti Enterovirus Clone
5-D8/1, Dako; dilution 1:250). Other reagents used were
the secondary antibody included in the Dako ARK
(Animal Research Kit) and peroxidase for mouse secondary antibodies (Dako). The methodological details are
described in our previous studies [57,58].
Pancreata were examined for the presence of neutrophils and macrophages by IHC. Rat anti-mouse Ly6G
(clone, 1A8, 1:250; Leinco), rabbit anti-mouse CD11b
(clone, EPR1344, 1:3500; Abcam), and their corresponding isotype controls were used to detect neutrophils and
macrophages, respectively. In brief, after deparaffinization, rehydration, and blockade of endogenous peroxidase
activity with 3% hydrogen peroxide, antigen retrieval was
performed by treating the sections with 10 mM sodium
citrate buffer (pH 6) in a pressure cooker. Sections were
then blocked for 30 min with 5% nonfat dry milk and
incubated overnight with primary antibodies at 4°C, followed by incubation with secondary antibodies, namely,
donkey anti-rat IgG or goat anti-rabbit IgG conjugated
with horse radish peroxidase (Vector Laboratories,
Burlingame, CA; and Abcam) for 2 h at room temperature. Diaminobenzoic acid was added as a substrate for
color development, and sections were counterstained
with hematoxylin.

220

S. SARMIROVA ET AL.

Acknowledgments
We thank the Norwegian financial support mechanism,
Mechanism EEA and Slovak Government - Project SK0082
received by S.B. We also thank the National Reference Center
for Identification of Enteral Viruses, Ministry of Health of the
Slovak Republic.

Disclosure statement
No potential conflict of interest was reported by the authors.

Funding
This work was supported by the National Reference Center
for Identification of Enteroviruses, Slovak Medical University
in Bratislava [NRC114508]and the Norwegian financial support mechanism, Mechanism EEA and Slovak Government
[SK0082].

ORCID
Shubhada Bopegamage
5565

http://orcid.org/0000-0002-8423-

References
[1] [cited 2019 Feb 21]. https://talk.ictvonline.org/ictvreports/ictv_online_report/positive-sense-rna-viruses
/picornavirales/w/picornaviridae
[2] Hunt JC, Schneider C, Menticoglou S, et al. Antenatal
and postnatal diagnosis of coxsackie B4 infection: case
series. Am J Perinatol Rep. 2012;2(1):1–6.
[3] Tan MGS, Yeo CHL. Enterovirus outbreak among
preterm infants in Singapore General Hospital: level
II nursery. J Clin Med Res. 2012;4(1):17–22.
[4] Abzug MJ, Levin MJ, Rotbart HA. Profile of enterovirus disease in the first two weeks of life. Pediatr Infect
Dis J. 1993;12(10):820–824.
[5] Axelsson C, Bondestam K, Frisk G, et al. Coxsackie
B virus infections in women with miscarriage. J Med
Virol. 1993;39(4):282–285.
[6] Bendig JW, Franklin OM, Hebden AK, et al.
Coxsackievirus B3 sequences in the blood of a neonate
with congenital myocarditis, plus serological evidence of
maternal infection. J Med Virol. 2003;70(4):606–609.
[7] Callen J, Paes BA. A case report of a premature infant
with coxsackie B1 meningitis. Adv Neonatal Care.
2007;7(5):238–247.
[8] Cheng LL, Ng PC, Chan PK, et al. Probable intrafamilial transmission of coxsackievirus B3 with vertical
transmission, severe early-onset neonatal hepatitis,
and prolonged viral RNA shedding. Pediatrics.
2006;118(3):929–933.
[9] Euscher E, Davis J, Holzman I, et al. Coxsackie virus
infection of the placenta associated with neurodevelopmental delays in the newborn. Obstet Gynecol. 2001;98
(6):1019–1026.

[10] Freund MW, Kleinveld G, Krediet TG, et al. Prognosis
for neonates with enterovirus myocarditis. Arch Dis
Child Fetal Neonatal Ed. 2010;95(3):206–212.
[11] Garcia AG, Basso NG, Fonseca ME, et al. Congenital echo
virus infection – morphological and virological study of
fetal and placental tissue. J Pathol. 1990;160(2):123–127.
[12] Hwang JH, Kim JW, Hwang JY, et al. Coxsackievirus
B infection is highly related with missed abortion in
Korea. Yonsei Med J. 2014;55(6):1562–1567.
[13] Iwasaki T, Monma N, Satodate R, et al. An immunofluorescent study of generalized coxsackie virus B3
infection in a newborn infant. Acta Pathol Jpn.
1985;35(3):741–748.
[14] Keyserling HL. Other viral agents of perinatal importance. Varicella, parvovirus, respiratory syncytial virus
and enteroviruses. In: Baniewicz C, Saunders WB, editors. Clinics in perinatology. Philadelphia: Company;
1997. p. 193–221.
[15] Konstantinidou A, Anninos H, Spanakis N, et al.
Transplacental infection of coxsackievirus B3 pathological findings in the fetus. J Med Virol. 2007;79(6):754–757.
[16] Mata L, Urrutia JJ, Serrato G, et al. Viral infections
during pregnancy and in early life. Am J Clin Nutr.
1977;30(11):1834–1842.
[17] Moore M, Morens DM. Enteroviruses including
poliovirus. In: Belshe R, editor. Textbook of human
virology. Littleton, MA: PSG Publishing company;
1984. p. 407–472.
[18] Orbach R, Mandel D, Lubetzky R, et al. Pulmonary
hemorrhage due to Coxsackievirus B infection-A call to
raise suspicion of this important complication as an
end-stage of enterovirus sepsis in preterm twin
neonates. J Clin Virol. 2016;82:41–45.
[19] Sauerbrei A, Gluck B, Jung K, et al. Congenital skin
lesions caused by intrauterine infection with coxackievirus B3. Infection. 2000;28(5):326–328.
[20] Smets K, Keymeulen A, Wollants E, et al. Detection of
enteroviral RNA on Guthrie card dried blood of
a neonate with fatal Coxsackie B3 myocarditis on day
17. J Clin Virol. 2008;42(2):207–210.
[21] Strong BS, Young SA. Intrauterine coxsackie virus, group
B type 1, infection: viral cultivation from amniotic fluid in
the third trimester. Am J Perinatol. 1995;12(2):78–79.
[22] Dahlquist GG, Frisk G, Ivarsson SA, et al. Indications
that maternal coxsackie B infection during pregnancy
is a risk factor for childhood-onset IDDM.
Diabetologia. 1995;38(11):1371–1373.
[23] Elfving M, Svensson J, Oikarinen S, et al. Maternal
enterovirus infection during pregnancy as a risk factor
in offspring diagnosed with type 1 diabetes between 15
and 30 years of age. Exp Diabetes Res.
2008;2008:271958.
[24] Frisk G, Diderholm H. Increased frequency of coxsackie B virus IgM in women with spontaneous
abortion. J Infect. 1992;24(2):141–145.
[25] Hyöty H, Hilunen M, Knip M, et al. A prospective
study of the role of coxsackie B and other enterovirus
infections in the pathogenesis of IDDM. Childhood
diabetes in Finland (DiMe) study group. Diabetes.
1995;44(6):652–657.
[26] Bopegamage S, Precechtelova J, Marosova L, et al.
Outcome of challenge with coxsackievirus B4 in

VIRULENCE

[27]

[28]
[29]

[30]

[31]

[32]

[33]
[34]
[35]
[36]

[37]

[38]

[39]

[40]

[41]

[42]

[43]

young mice after maternal infection with the same
virus during gestation. FEMS Immunol Med
Microbiol. 2012;64(2):184–190.
Coid CR, Ramsden DB. Retardation of foetal growth and
plasma protein development in foetuses from mice
injected with coxsackie B3 virus. Nature. 1973;241
(5390):460–461.
Dalldorf G, Gifford R. Susceptibility of gravid mice to
coxsackievirus infection. J Exp Med. 1954;99(1):21–27.
Jaïdane H, Halouani A, Jmii H, et al. Coxsackievirus B4
vertical transmission in a murine model. Virol J.
2017;14:16.
Lansdown AB. Influence of time of infection during
pregnancy with coxsackievirus B3 on maternal pathology and foetal growth in mice. Br J Exp Pathol. 1975;56
(2):119–123.
Lansdown AB, Coid CR. Pathological changes in pregnant mice infected with coxsackie B3 virus as a possible
cause of retarded foetal development. Br J Exp Path.
1974;55(2):101–109.
Modlin JF, Crumpacker CS. Coxsackievirus B infection
in pregnant mice and transplacental infection of the fetus.
Infect Immun. 1982;37(1):222–226.
Selzer G. Transplacental infection of the mouse fetus by
coxsackie viruses. Isr J Med Sci. 1969;5(1):125–127.
Soike K. Coxsackie B3 virus infection in the pregnant
mouse. J Infect Dis. 1967;117(3):203–208.
Modlin JF, Bowman M. Perinatal transmission of coxsackievirus B3 in mice. J Infect Dis. 1987;156(1):21–25.
Lansdown ABG. Influence of coxsackievirus
B infections on fetal growth in mice. Exp teratol.
1976;13(3):291–297.
Gicheva TA. Modelling coxsackie-virus infection in
pregnant mice in long-term experiment. J Hyg
Epidemiol Microbiol Immunol. 1988;32(4):439–445.
Dorner AA, Wegmann F, Butz S, et al. Coxsackievirusadenovirus receptor (CAR) is essential for early
embryonic cardiac development. J Cell Sci. 2005;118
(15):3509–3521.
Hwang JY, Lee KM, Kim YH, et al. Pregnancy loss
following coxsackievirus B3 infection in mice during
early gestation due to high expression of
coxsackievirus-adenovirus receptor (CAR) in uterus
and embryo. Exp Anim. 2014;63(1):63–72.
Xu R, Crowell RL. Expression and distribution of the
receptors for coxsackievirus B3 during fetal development of the Balb/c mouse and of their brain cells in
culture. Virus Res. 1996;46(1):157–170.
Adams-Waldorf KM, McAdams RM. Influence of
infection during pregnancy on fetal development.
Reproduction. 2013;146(5):R151–R162.
Fischer MA, Davies ML, Reider IE, et al. CD11b+,
Ly6G+ cells produce Type I interferon and exhibit
tissue protective properties following peripheral virus
infection. PLoS Pathog. 2011;7(11):e1002374.
Weirich E, Rabin RL, Maldonado Y, et al. Neutrophil
CD11b expression as a diagnostic marker for
early-onset neonatal infection. J Pediatr. 1998;13
2:445–451.

221

[44] Christensen JE, Andreasen SO, Christensen JP, et al.
CD11b expression as a marker to distinguish between
recently activated effector CD+T cells and memory
cells. Int Immunol. 2001;13(4):593–600.
[45] Andrews DM, Matthews VB, Sammels LM, et al. The
severity of murray valley encephalitis in mice is
linked to neutrophil infiltration and inducible nitric
oxide synthase activity in the central nervous system.
J Virol. 1999;73(10):8781–8790.
[46] Srivastava S, Khanna N, Saxena SK, et al. Degradation
of Japanese encephalitis virus by neutrophils. Int J Exp
Pathol. 1999;80(1):17–24.
[47] Daheshia M, Kanangat S, Rouse BT. Production of key
molecules by ocular neutrophils early after herpetic infection of the cornea. Exp Eye Res. 1998;67(6):619–624.
[48] Milligan GN. Neutrophils aid in protection of the vaginal
mucosae of immune mice against challenge with herpes
simplex virus type 2. J Virol. 1999;73(8):6380–6386.
[49] Thomas J, Gangappa S, Kanangat S, et al. On the
essential involvement of neutrophils in the immunopathologic disease: herpetic stromal keratitis.
J Immunol. 1997;158(3):1383–1391.
[50] Tran EH, Prince EN, Owens T. IFN-gamma shapes
immune invasion of the central nervous system via
regulation of chemokines. J Immunol. 2000;164
(5):2759–2768.
[51] Beamer WG, Wilson MC, Leiter EH. Endocrinology. In:
Foster HL, Small JD, Fox JG, editors. The mouse in biomedical research. New York: Academic Press; 1983. p.
165–245.
[52] Jørgensen MC, Ahnfelt-Rønne J, Hald J, et al. An
illustrated review of early pancreas development in
the mouse. Endocr Rev. 2007;28(6):685–705.
[53] Dahlquist GG, Forsberg J, Hagenfeldt L, et al.
Increased prevalence of enteroviral RNA in blood
spots from newborn children who later developed
type 1 diabetes: a population-based case-control
study. Diabetes Care. 2004;27(1):285–286.
[54] Viskari HR, Roivainen M, Reunanen A, et al. Maternal
first-trimester enterovirus infection and future risk of
type 1 diabetes in the exposed fetus. Diabetes. 2002;51
(8):2568–2571.
[55] Bopegamage S, Kovacova J, Vargova A, et al. Coxsackie
B virus infection of mice: inoculation by the oral route
protects the pancreas from damage, but not from
infection. J Gen Virol. 2005;86:3271–3280.
[56] Bopegamage S, Borsanyiova M, Vargova A, et al.
Coxsackievirus infection of mice. I. Viral kinetics and
histopathological changes in mice experimentally
infected with coxsackieviruses B3 and B4 by oral route.
Acta Virol. 2003;47(4):245–251.
[57] De Leeuw N, Melchers WJG, Willemse DFM, et al.
The diagnostic value of PCR for the diagnosis of
enteroviral infections. Serodiag Immun Inf D.
1994;6(4):189–195.
[58] Precechtelova J, Borsanyiova M, Stipalova D, et al.
Pathophysiology of the pancreas after oral infection
of genetically diverse mice with coxsackievirus B4-E2.
Arch Virol. 2014;160(1):103–115.

